Karyopharm Therapeutics, Inc. (KPTIQ)
0.0174
-0.02
(-56.50%)
USD |
OTCM |
Nov 10, 16:00
0.0163
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Total Liabilities (Quarterly) : 441.48M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 441.48M |
| March 31, 2026 | 397.06M |
| December 31, 2025 | 410.38M |
| September 30, 2025 | 365.49M |
| June 30, 2025 | 343.80M |
| March 31, 2025 | 333.60M |
| December 31, 2024 | 350.44M |
| September 30, 2024 | 349.12M |
| June 30, 2024 | 346.12M |
| March 31, 2024 | 373.41M |
| December 31, 2023 | 376.64M |
| September 30, 2023 | 370.36M |
| June 30, 2023 | 369.08M |
| March 31, 2023 | 370.97M |
| December 31, 2022 | 374.83M |
| September 30, 2022 | 371.52M |
| June 30, 2022 | 372.82M |
| March 31, 2022 | 377.11M |
| December 31, 2021 | 384.98M |
| September 30, 2021 | 380.07M |
| June 30, 2021 | 369.70M |
| March 31, 2021 | 314.55M |
| December 31, 2020 | 262.50M |
| September 30, 2020 | 253.82M |
| June 30, 2020 | 250.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 249.99M |
| December 31, 2019 | 245.19M |
| September 30, 2019 | 237.88M |
| June 30, 2019 | 155.63M |
| March 31, 2019 | 165.93M |
| December 31, 2018 | 158.02M |
| September 30, 2018 | 48.91M |
| June 30, 2018 | 43.12M |
| March 31, 2018 | 50.84M |
| December 31, 2017 | 50.83M |
| September 30, 2017 | 22.60M |
| June 30, 2017 | 19.04M |
| March 31, 2017 | 17.07M |
| December 31, 2016 | 18.14M |
| September 30, 2016 | 16.69M |
| June 30, 2016 | 17.33M |
| March 31, 2016 | 15.10M |
| December 31, 2015 | 17.08M |
| September 30, 2015 | 16.38M |
| June 30, 2015 | 15.97M |
| March 31, 2015 | 16.52M |
| December 31, 2014 | 13.54M |
| September 30, 2014 | 7.351M |
| June 30, 2014 | 5.999M |
| March 31, 2014 | 5.185M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 225.53M |
| Tonix Pharmaceuticals Holding Corp. | 42.94M |
| Minerva Neurosciences, Inc. | 195.80M |
| Corbus Pharmaceuticals Holdings, Inc. | 38.14M |
| Ocugen, Inc. | 125.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 111.32M |
| Shareholders Equity (Quarterly) | -330.17M |
| Debt to Equity Ratio | -0.7759 |
| Current Ratio | 0.7925 |
| Net Debt Paydown Yield | -6.27% |